COMPLETED

Continuous Glucose Monitoring, Contingency Management, and Motivational Interviewing for Patients With Type 2 Diabetes in Kansas City

Talk to us

Conditions

Type 2 DiabetesGlucosecontingency managementmotivational interviewing

Quick Navigation

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

This study is evaluating a behavioral treatment program that uses diabetes coaching and financial rewards in addition to continuous glucose monitoring to improve diabetes management in adult patients with type 2 diabetes. This study will evaluate if this behavioral treatment program increases individual adherence to a diabetes treatment plan and improves blood sugar management.

Official Title

COntinuous Glucose Monitoring, Contingency Management, and Motivational InTerviewing for Patients With TypE 2 Diabetes in Kansas City

Quick Facts

Study Start:2024-05-01
Study Completion:2025-08-12
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:COMPLETED

Study ID

NCT06374186

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years to 65 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. 1. Diagnosed with type 2 diabetes
  2. 2. Age 18 to 65
  3. 3. Hemoglobin A1c (blood draw or point-of-care) test available within the last 3 months
  4. 4. Most recent hemoglobin A1c result between 8.0 and 11.0
  5. 5. Currently receiving treatment for diabetes by a licensed healthcare provider.
  6. 6. Reliable access to a personal smart phone that is compatible with CGM
  7. 7. English speaking
  1. 1. Type 1 diabetes
  2. 2. Secondary type 2 diabetes (diagnosis secondary to other medical conditions such as pancreatitis, Cystic Fibrosis, or Cushing disease)
  3. 3. Prescribed short-acting (mealtime) insulin as part of diabetes treatment plan
  4. 4. Known or acknowledged active substance use disorder or that would interfere or negatively impact participation in the study
  5. 5. Diagnosis of a medical/psychiatric condition that would prevent participation in the study (e.g., Intellectual Disability, Alzheimer's disease, Traumatic Brain Injury, Schizophrenia)

Contacts and Locations

Principal Investigator

Jared Bruce, PhD
PRINCIPAL_INVESTIGATOR
University of Missouri, Kansas City

Study Locations (Sites)

University of Missouri - Kansas City School of Medicine
Kansas City, Missouri, 64108
United States

Collaborators and Investigators

Sponsor: University of Missouri, Kansas City

  • Jared Bruce, PhD, PRINCIPAL_INVESTIGATOR, University of Missouri, Kansas City

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2024-05-01
Study Completion Date2025-08-12

Study Record Updates

Study Start Date2024-05-01
Study Completion Date2025-08-12

Terms related to this study

Keywords Provided by Researchers

  • Type 2 Diabetes
  • Glucose
  • contingency management
  • motivational interviewing

Additional Relevant MeSH Terms

  • Type 2 Diabetes